In Vitro Protein Expression Market
In Vitro Protein Expression Market By Product Type (E.coli Cell-Free Protein Expression System, Rabbit Reticulocytes Cell-Free Protein Expression System, Wheat Germ Cell-Free Protein Expression System, Insect Cells Cell-Free Protein Expression System, and Mammalian Cell-Free Protein Expression System), By Application (Protein Labeling, Protein-Protein Interaction, Protein Purification, and Continuous Flow Expression), By, Expression Mode (Continuous Flow Expression and Batch Expression), By End User (Biotechnological Companies, Pharmaceutical Companies, Contract Research Organizations, and Academic and Research Institutes), and By Region- Global Market Report (2024 to 2034)
Analysis of In Vitro Protein Expression Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
In Vitro Protein Expression Market Outlook (2024 to 2034)
The In Vitro protein expression market is estimated to be US$ 238.2 million in 2024 and is forecast to reach a value of US$ 428.8 million by 2034, with a projected CAGR of 6.1% from 2024 to 2034 owing to the rising demand for recombinant proteins in research and diagnostics globally.
The market for in vitro protein expressions has experienced remarkable growth in the past few years. This rise in demand is attributed primarily to the increased demand for biopharmaceuticals and therapeutic proteins in the treatment of various diseases. The market is also showing promising growth in the future in countries where the government is investing extensively in biotechnology and healthcare infrastructure.
|Estimated Market Value (2024E)
|US$ 238.2 million
|Forecasted Market Value (2034F)
|US$ 428.8 million
|Global Market Growth Rate (2024 to 2034)
|Continuous Flow Segment Growth Rate (2024 to 2034)
|Academic and Research Institutes Segment Growth Rate (2024 to 2034)
|North America Market Share (2024)
|East Asia Market Share (2024)
|Key Companies Profiled
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Which Factors Have Driven the Global Surge in In Vitro Protein Expression Demand?
"Biopharmaceutical Development and Precision Medicine Driving the Demand for In Vitro Protein Expression"
The last few years have seen a considerable rise in the significance of biopharmaceuticals, such as monoclonal antibodies, vaccines, and therapeutic proteins, in the pharmaceutical industry. This has appreciably augmented the demand for in vitro protein expressions, as they are a crucial component in producing these biopharmaceuticals. Researchers in various industries use these systems to express and produce the specific proteins that form the basis of these drugs.
The in vitro protein expression market share has also touched the skies in the past few years due to the growing inclination toward precision medication in the general population. It is integral to precision medicine as it allows for the production of proteins tailored to the specific genetic and molecular profiles of patients. This has made in vitro protein expressions a perfect choice for healthcare facilities in the production of diagnostic proteins, therapeutic agents, or vaccines, thus amplifying the market growth.
"Advancements in Genetic Engineering and Industrial Applications to Boost Market Growth"
The demand for in vitro protein expressions in the advanced medical industry is also skyrocketing due to continuous advancements in genetic therapy. Innovations, such as CRISPR-Cas9, synthetic biology, and gene synthesis, have significantly pushed the efficiency and precision of in vitro protein expressions. This has increased the reliance of pharma companies on these expressions, contributing positively to the market valuation.
In vitro protein expressions find their applications in the pharma and biopharma sector and a broad spectrum of industries, such as agriculture, food, environmental science, cosmetics, chemicals, etc. In the agriculture sector, in vitro protein expressions are involved in plant modification and crop protection. These protein expressions are also used to produce proteins used in cosmetic formulations and skincare products. These varied applications have significantly amplified the product demand.
Which Factors Present Challenges to the Expansion of the In Vitro Protein Expression Market?
"Complex Protein Structures, Costs of Production, and Limited Protein Yield to Slow down Market Growth"
The in vitro protein expression market faces many challenges in the form of inconsistent protein yields, high upfront costs in setting up the manufacturing unit, and complexities in the production process of these protein expressions. There is also an acute shortage of skilled workers who can navigate the intricacies of in vitro protein expression technologies. This is one of the major concerns in the market. Scaling up in vitro protein expression for industrial-level production is another big hurdle manufacturing companies must overcome in this industry. Meeting regulatory standards for the production of proteins intended for therapeutic or diagnostic use is also contributing negatively to the market growth.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
The North American in vitro protein expression market is poised for exceptional growth, projecting a modest CAGR of 6.20% through 2034 due to increasing product demand in key countries, notably the United States and Mexico. In 2024, the United States will dominate the in vitro protein expression industry with an estimated 71.10% market share. Meanwhile, the East Asian in vitro protein expression market is anticipated to exhibit substantial progress, aiming for a 6.50% CAGR in 2024. In this region, China emerges as the key player in the industry, commanding a significant share of 53.10% in 2024.
Why is the United States Leading the In Vitro Protein Expression Market in the North American Region?
"Advanced Research Infrastructure and Access to Skilled Workforce in the Country to Augment Growth"
The North American market stood at US$ 91 million in 2024, acquiring a revenue share of 38.30%, and is further projected to expand at a CAGR of 6.20% through 2034. The in vitro protein expression industry in the United States is estimated to be worth US$ 65 million in 2024 and is projected to rise at a CAGR of 6.5% through 2034.
The United States of America has a robust biopharmaceutical industry that extensively utilizes in vitro protein expression to produce biologics, including monoclonal antibodies, vaccines, and therapeutic proteins. This is one of the major reasons why the United States is one of the leading countries in the market for in vitro protein expressions. Besides this, investments by private and public organizations in the research and development of biotechnological processes contribute significantly to the overall market.
Why is China Commanding the East Asian In Vitro Protein Expression Market?
"Strategic Government Initiatives, and Increasing Academic and Industrial Collaborations to Help Market Expansion"
The Chinese in vitro protein expression industry is estimated to be worth US$ 13 million in 2024, garnering a share of 53.1% in the East Asian region, and it is likely to record a CAGR of 7.10% through 2034.
Collaborations between academic institutions, research organizations, and industry players in China promote knowledge exchange and accelerate the translation of research findings into practical applications. These collaborative efforts are enhancing the adoption and development of in vitro protein expression technologies in the country. Also, constant support by the Chinese government to promote the biotechnology sector is encouraging new companies to enter the market. All these factors collectively make China one of the leaders in the in vitro protein expression market.
Based on the product type, the E.coli cell-free protein expression system segment is estimated to hold a 47.30% market share in 2024. Simultaneously, the mammalian cell-free protein expression system segment is anticipated to secure a 20.20% share, contributing significantly to the market's resource diversity and stability. Based on end users, the academic and research institutes segment marks its dominance in the in vitro protein expression market, with a share of 50.4% in 2024.
Why are Academic and Research Institutes Relying on In Vitro Protein Expression for Advanced Biopharmaceutical Research?
"Precise Control and Flexibility, and Potential Therapeutic Applications Makes In Vitro Protein Expression a Perfect Choice"
Academic and research institutes rely on in vitro protein expression for advanced biopharmaceutical research. It allows precise control over experimental conditions, facilitating the production of specific proteins critical for studying biological processes and disease mechanisms. This controlled environment allows researchers to investigate protein structure, function, and interactions.
The demand for these protein expressions in research and development institutes is also gaining a lot of impetus due to their flexibility. In vitro systems enable the study of various protein variants, supporting the development of more effective and targeted pharmaceutical interventions. This makes it one of the crucial components in drug development and advanced biopharmaceutical research, thus elevating its demand in academia.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
The global in vitro protein expression market is driven by continuous innovations using gene therapy and advanced biopharmaceutical research. Industry giants in this market invest millions of dollars in making new technological breakthroughs. Key market players are collaborating with research institutes and academia to enhance their capabilities further. This fosters knowledge exchange and technological advancements within the scientific community, further enhancing the efficiency and applicability of in vitro protein expression systems.
- In October 2023, Taysha Gene Therapies presented compelling preclinical in vitro data on TSHA-102 in Rett Syndrome at the European Society of Gene & Cell Therapy Congress, showcasing support for miRARE regulation of MECP2 expression.
- Swiss-based Lonza Group, one of the leading countries in the in vitro protein expression market, has expanded its early development services to North America with a new laboratory in Cambridge, Massachusetts. The move aims to support US biotechs in the commercialization of novel therapies.
In Vitro Protein Expression Market - Segmentation
By Product Type:
- E.coli Cell-Free Protein Expression System
- Rabbit Reticulocytes Cell-Free Protein Expression System
- Wheat Germ Cell-Free Protein Expression System
- Insect Cells Cell-Free Protein Expression System
- Mammalian Cell-Free Protein Expression System
- Protein Labeling
- Protein-Protein Interaction
- Protein Purification
- Continuous Flow Expression
By Expression Mode:
- Continuous Flow Expression
- Batch Expression
By End User:
- Biotechnological Companies
- Pharmaceutical Companies
- Contract Research Organizations
- Academic and Research Institutes
- North America
- Latin America
- Asia Pacific
- Middle East & Africa (MEA)
- FAQs -
What was the value of the in vitro protein expression market in 2019?
The global in vitro protein expression market was worth US$ 177.8 million in 2019.
What is the sales outlook for in vitro protein expression in 2024?
The sales outlook for in vitro protein expression is likely to be valued at US$ 238.2 million in 2024.
What is the demand forecast for in vitro protein expression for the decade?
Demand for in vitro protein expression is estimated to reach a market value of US$ 428.8 million by the end of 2034.
What is the adoption growth projection for in vitro protein expression solutions?
The adoption of in vitro protein expression is projected to rise at a CAGR of 6.10% through 2034.
At what rate is the market in North America predicted to grow?
North America’s in vitro protein expression market is forecasted to expand at a CAGR of 6.20% through 2034.